HIV neuropathy in South Africans: frequency, characteristics, and risk factors.
about
Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trialsRandomized, Double-Blind, Crossover Trial of Amitriptyline for Analgesia in Painful HIV-Associated Sensory NeuropathyOver-reported peripheral neuropathy symptoms in a cohort of HIV infected and uninfected Rwandan women: the need for validated locally appropriate questionnaires.Screening for HIV-associated peripheral neuropathy in resource-limited settingsWellbeing among sub-Saharan African patients with advanced HIV and/or cancer: an international multicentred comparison study of two outcome measuresImplementation of a validated peripheral neuropathy screening tool in patients receiving antiretroviral therapy in Mombasa, KenyaSensory, psychological, and metabolic dysfunction in HIV-associated peripheral neuropathy: A cross-sectional deep profiling study.Symptomatology of peripheral neuropathy in an African languageCentral nervous system disorders after starting antiretroviral therapy in South Africa.Role of TNF block genetic variants in HIV-associated sensory neuropathy in black Southern Africans.Plasma cytokine profiles in HIV-1 infected patients developing neuropathic symptoms shortly after commencing antiretroviral therapy: a case-control study.Neurology and the Global HIV Epidemic.Training needs and evaluation of a neuro-HIV training module for non-physician healthcare workers in western KenyaNeurologic manifestations of human immunodeficiency virus-2: dementia, myelopathy, and neuropathy in West Africa.The relationship between race and HIV-distal sensory polyneuropathy in a large cohort of US womenMeasures of small-fiber neuropathy in HIV infection.Sensory neuropathy and metabolic risk factors in human immune deficiency virus infected South Africans receiving protease inhibitors.Development, Validation, and Field-Testing of an Instrument for Clinical Assessment of HIV-Associated Neuropathy and Neuropathic Pain in Resource-Restricted and Large Population Study SettingsPrevalence and incidence of neurological disorders among adult Ugandans in rural and urban Mukono district; a cross-sectional study.HIV-associated sensory neuropathy in HIV-1 infected patients at the Douala General Hospital in Cameroon: a cross-sectional study.Effects of a reduced dose of stavudine on the incidence and severity of peripheral neuropathy in HIV-infected adults in South AfricaMitochondrial genomics and antiretroviral therapy-associated metabolic complications in HIV-infected Black South Africans: a pilot studyHIV-related neuropathy: current perspectives.Prevalent neuropathy in a cohort of HIV-infected Kenyan sex workers using antiretroviral drugs.Peripheral neuropathy in HIV-infected and uninfected patients in Rakai, Uganda.Isoniazid-induced polyneuropathy in a tuberculosis patient - implication for individual risk stratification with genotyping?High prevalence of "non-dipping" blood pressure and vascular stiffness in HIV-infected South Africans on antiretroviralsLow-power transcutaneous current stimulator for wearable applications.Targeting JNK to prevent antiretroviral neuropathy.Disability and HIV: What drives this relationship in Eastern and Southern Africa?
P2860
Q21562140-98209DCD-D11E-4A85-B9D5-8275730F4410Q28547239-DF80D376-E6FC-4DA6-BB42-140424DC43F2Q30390516-AE3056C0-17FA-449D-AF00-6F27EA8BB49EQ33603950-784B37D7-2BEE-496C-AF76-BDBCD137EB5DQ33776704-23C20598-C2DD-4EAF-B6FE-18B5F508634BQ34087372-91604C36-E363-48E6-A19F-AE5B729B1B07Q34194723-2F82D39C-00FF-4FA7-86A1-9C9614A9F017Q34731211-33EB224E-6E65-483B-B652-ECF22A3B8157Q34799534-3C7B9F03-9F06-4C9C-88AB-05FB08FEA923Q35079928-5C433C36-6D9D-4ABB-A653-8F68AC527892Q35089902-3B914F28-16AF-4966-A59A-40D3DF14B603Q35149362-4F78B9C8-D381-4BA1-A376-288E0EC1E6F2Q35195299-7A0FBBC9-9D9A-45B1-AFA4-5C49AB48B7C6Q35751491-66480A33-9F6F-4908-A42B-4EAC65FE9C53Q35823133-E34F7E0A-CAFF-4660-BA50-2EA197C6AC33Q36025928-607580BF-D21E-4A44-9013-B223BE23F7CCQ36086086-A94826A0-3798-4376-AB8E-3CC69C855682Q36169291-B7B09798-B36F-43AC-9658-D78B2DABCEB7Q36195363-144E71A8-1AC7-4FC8-B67B-4B428EC119B0Q36478702-0FB12532-2C10-4CC6-BDC0-5334DA3C5927Q36870758-DBCBE46F-741D-4ED4-9C87-31536AA7C6AEQ36937849-0614EA8C-C3B5-4CB8-A3A8-39738B73107EQ37178574-0F4B6C14-5763-4B3B-9D11-DE50C10A657DQ37608857-520B5EE9-CFA0-4E29-973B-1ED4F9516C50Q38849779-97D47908-5C95-4D89-B3A0-B2854CDF16AEQ41875502-EE3D74A7-081D-4998-B89C-CAA3DB99087FQ41933658-35366BB2-83F1-4D2A-91C0-57A29D5A3728Q42281053-97BB5A4C-F1B8-4419-995F-CE9086992076Q42315766-D346214A-A05B-4A56-9E97-BC4A75B734CEQ54868352-FF70DD46-5AF3-450D-B648-26204D8F631E
P2860
HIV neuropathy in South Africans: frequency, characteristics, and risk factors.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
HIV neuropathy in South Africans: frequency, characteristics, and risk factors.
@en
HIV neuropathy in South Africans: frequency, characteristics, and risk factors.
@nl
type
label
HIV neuropathy in South Africans: frequency, characteristics, and risk factors.
@en
HIV neuropathy in South Africans: frequency, characteristics, and risk factors.
@nl
prefLabel
HIV neuropathy in South Africans: frequency, characteristics, and risk factors.
@en
HIV neuropathy in South Africans: frequency, characteristics, and risk factors.
@nl
P2093
P50
P356
P1433
P1476
HIV neuropathy in South Africans: frequency, characteristics, and risk factors.
@en
P2093
Jean Maritz
Joel A Dave
Naomi S Levitt
Taylor B Harrison
P2860
P304
P356
10.1002/MUS.21535
P577
2010-05-01T00:00:00Z